28 Oct Cuba vs. COVID-19: 10 Strategies that Matter for Us
Posted at 20:13h
in MEDICC in the Media
Cuba’s public health system records just over 6,000 COVID-19 cases and under 150 deaths since March. The country’s 11 million people are battered by the virus, economic woes and the US embargo. Yet, they are headed into a “new normal” recovery period and their research teams have developed Latin America’s only COVID-19 vaccine already in clinical trials.
What did Cuba do right? What challenges still lie ahead? The lessons we’re not seeing on prime time. Join MEDICCC Review Editors Dr. C. William Keck, Gail Reed, and Dr. Caitlin Baird in the replay of this important conversation.